AC Immune SA's market cap is currently ―. The company's EPS TTM is $-0.885; its P/E ratio is -2.42; AC Immune SA is scheduled to report earnings on April 27, 2023, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	SFr. 3.93M	SFr. 0.00	SFr. 0.00	SFr. 0.00	SFr. 0.00
Gross Profit	-	-	-	-	-
EBIT	SFr. -13.44M	SFr. -19.51M	SFr. -18.69M	SFr. -21.10M	SFr. -15.74M
EBITDA	SFr. -12.86M	SFr. -18.94M	SFr. -18.09M	SFr. -20.47M	SFr. -15.10M
Net Income Common Stockholders	SFr. -13.52M	SFr. -19.64M	SFr. -18.85M	SFr. -21.28M	SFr. -15.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	SFr. 140.50M	SFr. 154.15M	SFr. 173.84M	SFr. 198.22M	SFr. 188.58M
Total Assets	SFr. 205.56M	SFr. 216.79M	SFr. 235.52M	SFr. 261.44M	SFr. 203.40M
Total Debt	SFr. 2.48M	SFr. 2.63M	SFr. 2.77M	SFr. 2.91M	SFr. 2.57M
Net Debt	SFr. -138.02M	SFr. -151.52M	SFr. -171.07M	SFr. -195.31M	SFr. -186.01M
Total Liabilities	SFr. 15.50M	SFr. 13.97M	SFr. 21.39M	SFr. 29.46M	SFr. 24.18M
Stockholders Equity	SFr. 190.05M	SFr. 202.81M	SFr. 214.13M	SFr. 231.98M	SFr. 179.22M
Cash Flow	-
Free Cash Flow	SFr. -13.66M	SFr. -20.02M	SFr. -23.68M	SFr. -18.55M	SFr. -14.99M
Operating Cash Flow	SFr. -13.54M	SFr. -19.48M	SFr. -23.14M	SFr. -17.83M	SFr. -14.50M
Investing Cash Flow	SFr. -5.12M	SFr. 24.46M	SFr. -540.00K	SFr. -21.72M	SFr. -495.00K
Financing Cash Flow	SFr. -142.00K	SFr. -137.00K	SFr. -916.00K	SFr. 28.73M	SFr. 4.33M

Currency in CHF

AC Immune SA Earnings and Revenue History

Income Statement >

AC Immune SA Debt to Assets

Balance Sheet >

AC Immune SA Cash Flow

Cash Flow >

AC Immune SA Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing